News
Market Data
Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.
The current TARS market cap is 529.69M. The company's latest EPS is -1.9 and P/E is -8.55.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 57.03M | 25.82M |
| Operating Income | -1.35M | -4.3M | -27M | -12.16M | -62.71M |
| Net Income | -1.32M | -4.67M | -26.81M | -13.83M | -62.09M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 2.39M | 58.32M | 171.97M | 178.91M | 227.86M |
| Total Liabilities | 179k | 919k | 5.99M | 12.18M | 34.96M |
| Total Equity | -1.35M | -6.01M | 165.98M | 166.73M | 192.9M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -1.18M | -3.67M | -21.14M | 3.75M | -49.03M |
| Investing | -7k | -175k | -456k | -586k | -144.63M |
| Financing | 3.56M | 59.45M | 131.77M | 21k | 93.99M |
| Market Cap | 529.69M |
| Price to Earnings Ratio | -8.55 |
| Price to Sales Ratio | 20.56 |
| Price to Cash Ratio | 7.38 |
| Price to Book Ratio | 2.75 |
| Dividend Yield | - |
| Shares Outstanding | 32.62M |
| Average Volume (1 week) | 265.76k |
| Average Volume (1 Month) | 399.36k |
| 52 Week Change | -7.62% |
| 52 Week High | 25.25 |
| 52 Week Low | 11.33 |
| Spread (Intraday) | 10.81 (41.88%) |
| Company Name | Tarsus Pharmaceuticals Inc |
| Address |
3500 s dupont hwy dover, delaware 19901 |
| Website | https://www.tarsusrx.com |
| Industry | biological pds,ex diagnstics (2836) |
